NDC product
Menstrual Relief
NDC 11673-390 · Target Corporation
Key facts
| Product NDC | 11673-390 |
|---|---|
| Proprietary name | Menstrual Relief |
| Nonproprietary name | Acetaminophen, Caffeine and Pyrilamine maleate |
| Substances | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Target Corporation |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M013 |
| Pharmacologic classes | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS] |
| Marketing start | Apr 1, 2019 |
| Marketing end | Jan 31, 2028 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory